Trade-offs between clinical performance and test accessibility in tuberculosis diagnosis: a multi-country modelling approach for target product profile development
Authors:
Open Access
- 13 June 2024
- journal article
- research article
- Published by Elsevier in The Lancet Global Health
- Vol. 12 (7) , e1139-e1148
Abstract
No abstract availableKeywords
Funding Information
- Bill & Melinda Gates Foundation
This publication has 9 references indexed in Scilit:
- Preferences of healthcare workers using tongue swabs for tuberculosis diagnosis during COVID-19PLOS Global Public Health, 2023
- Gaps and Interventions across the Diagnostic Care Cascade of TB Patients at the Level of Patient, Community and Health System: A Qualitative Review of the LiteratureTropical Medicine and Infectious Disease, 2022
- Reimagining the status quo: How close are we to rapid sputum-free tuberculosis diagnostics for all?EBioMedicine, 2022
- The latent tuberculosis cascade-of-care among people living with HIV: A systematic review and meta-analysisPLOS Medicine, 2021
- Newer Molecular Diagnostic Tests for TuberculosisJournal of Advanced Lung Health, 2021
- Tuberculosis: treatment failure, or failure to treat? Lessons from India and South AfricaBMJ Global Health, 2019
- Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better?European Respiratory Journal, 2016
- Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIFThe Lancet Global Health, 2015
- Pediatric Tuberculosis: Global Overview and ChallengesClinical Infectious Diseases, 2010